Filing Details

Accession Number:
0001387131-15-002579
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-08-17 17:29:54
Reporting Period:
2015-08-13
Filing Date:
2015-08-17
Accepted Time:
2015-08-17 17:29:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
887247 Adamis Pharmaceuticals Corp ADMP Pharmaceutical Preparations (2834) 820429727
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1277431 B Robert Rothermel C/O Adamis Pharmaceuticals Corporation
11682 El Camino Real, Suite 300
San Diego CA 92130
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-08-13 5,000 $3.30 25,000 No 4 P Direct
Common Stock Acquisiton 2015-08-14 2,000 $3.40 27,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. The price reported in Column 4 is a weighted avergae price. These shares were purchased in multiple transactions at prices ranging from $3.24 to $3.30, inclusive. The reporting person undertakes to provide to Adamis Pharmaceuticals Corporation, any security holder of Adamis Pharmaceuticals Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.
  2. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.358 to $3.426, inclusive. The reporting person undertakes to provide to Adamis Pharmaceuticals Corporation, any security holder of Adamis Pharmaceuticals Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (2) to this Form 4.